|
 |
NiaspanThis page contains recent news articles, when available, and an overview of Niaspan but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Abbott Labs' cholesterol drug Niaspan is growing prescription share nicely after a clinical trial highlighted its potential as part of a one-two punch in ... Medical Marketing and Media Treating Coronary Heart Disease: Is Niaspan Better than Ezetimibe? - Jan 1, 2010 The HALTS study, presented on November 16, 2009 at the annual meeting of the American Heart Association, appeared to show that Niaspan is more effective ... Ethiopian Review ARBITER leaves some lasting marks on Merck - Dec 21, 2009 The study showed that Abbott Labs' Niaspan, an extended-release niacin, bested ezetimibe—an ingredient in Merck's cholesterol-lowering drugs Zetia and ... Medical Marketing and Media US FDA: unlikely Merck's Vytorin ups cancer risk - Dec 22, 2009 N) drug Niaspan, which raises HDL or "good" cholesterol, appeared more effective and safer than Zetia for reducing build-up of plaque in neck arteries. ... Reuters 2009 Big Pharma DOTY Nominee: Abbott/Solvay and the Foreign Cash Dilemma - Dec 17, 2009 Abbott's $3.7 billion buyout of Kos in 2006 added Niaspan and Simcor just before Pfizer's next-big-thing torcetrapib blew up, and with the $6.9 billion ... The IN VIVO Blog (blog) Abbott Labs' Deal with Teva Pharma Is 'Phat News' for Lipid-Lowering Franchise - Dec 14, 2009 ...commercial appeal of Abbott's lipid franchise, which also includes Niaspan (extended-release niacin) and Simcor (simvastatin/niacin extended release), ... BNET "Good" cholesterol less protective with diabetes - Dec 23, 2009 Because it was a small study, the team said more research is needed to see if diabetics will benefit from getting extended-release niacin, such as Niaspan ... National Post ABT Seeks Simcor Label Expansion - Analyst Blog - Dec 18, 2009 Simcor is a fixed-dose combination of Niaspan (niacin extended-release) and Merck's (MRK) Zocor (simvastatin), recommended for use in people who cannot ... Benzinga 800 euros pour les donneurs de graisse - Dec 17, 2009 Cette molécule est déjà commercialisée dans le médicament Niaspan utilisé pour faire baisser le taux de lipides au profit du bon cholestérol. ... LaDépêche.fr Colesterol "bueno" es menos protector en los diabéticos - Dec 23, 2009 ...niacina de acción prolongada, como Niaspan de Abbott Laboratories Inc. En Estados Unidos, alrededor del 11 por ciento de los adultos tiene diabetes. ... La Estrella de Valparaíso US EQUITIES WEEK AHEAD: Retailers, GM Report; Inflation Data - Nov 13, 2009 ...(MRK) and Niaspan from Abbott Laboratories (ABT) will be presented Monday morning at the scientific sessions of the American Heart Association in Orlando, ... CNNMoney.com Merck Cholesterol Pill Sales May Drop 20% After Study - Nov 10, 2009 16, pits Merck's drugs against Abbott Laboratories' Niaspan, a modified form of vitamin B3 used to maintain healthy cholesterol levels. A win by Niaspan may ... Bloomberg The Next Vytorin Study: Why Is Everybody So Worked Up? - Nov 13, 2009 The trial was stopped early, and most observers seem to think that happened because Niaspan performed significantly better than Vytorin. ... Wall Street Journal (blog) Merck/Schering Cholesterol Drugs At Another Crossroads - Nov 4, 2009 Although the data aren't yet known, some doctors and investors suspect the " Arbiter 6" trial will show that Abbott Laboratories' (ABT) Niaspan cholesterol ... CNNMoney.com Study: Abbott's Niaspan reduces arteries' plaque buildup - Nov 2, 2009 Combining Abbott Laboratories' cholesterol pill Niaspan with an older medicine, called a statin, reduced plaque buildup more than the statin alone, ... Chicago Daily Herald Low cholesterol is really good for you - Nov 4, 2009 ...put on timed-release niacin (available as a dietary supplement at most drug stores, as well as in the drug Niaspan) and now those numbers are tickety-boo. SmartPlanet.com Imaging study shows plaque regression with niacin vs placebo - Oct 30, 2009 Dr Justin MS Lee (University of Oxford, UK) and colleagues report that 2 g of modified-release nicotinic acid (Niaspan, Abbott Laboratories) daily, ... TheHeart.Org US Drug Makers 3Q Helped By Cost Cuts, Major Product Sales - Oct 22, 2009 Pressure could mount next month when researchers present the findings of a clinical trial comparing Zetia with Abbott Laboratories' (ABT) Niaspan. ... NASDAQ 스타틴+니아스íŒ?, ê²½ë?™ë§¥ 플ë?¼í?¬ ê°?소 - Nov 2, 2009 ...ì• ë³´íŠ¸(Abbott)ì?˜ '니아스íŒ?'(Niaspan, niacin)ì?„ 스타틴ì—? 추가했ì?„ ë•Œ ê²½ë?™ë§¥ì?˜ 플ë?¼í?¬ 축ì ?ì?„ 줄ì?¼ 수 있는 것으로 나타났다. ì?´ë²ˆì—? 미êµì‹¬ìž¥í•™íšŒ ì €ë„?ì—? 발표ë?œ ... 디지틀보사 * ما الذي لا يقوله الأطباء؟ - Oct 30, 2009 ويمكنك شراؤه من مخازن الطعام الصØÙŠ تØت أسماء تجارية Niaspan ÙˆNiacorØŒ ولكن لعلاج ارتÙ?اع الكولسترول Ù?ÙŠ الدم Ù?إنك تØتاج إلى جرعة أكبر من تلك الموجودة Ù?ÙŠ معظم ... الرايـة Abbott Makes A Big Bet On Good Cholesterol - Nov 6, 2006 Kos has two drugs on the market: Niaspan, an extended release form of niacin which ... "Abbott is likely to do well with Niaspan, at least in the near-term, ... Forbes Merck HDL drug causes less flushing than Niaspan - Mar 31, 2008 By Ransdell Pierson. NEW YORK (Reuters) - Merck & Co's (MRK.N) Cordaptive pill to raise "good" HDL cholesterol caused less facial flushing in a study than ... Reuters Priced Out Of Heart Disease - Jul 6, 2005 Researchers hope to prove that the addition of Niaspan cuts heart attacks, ... Niaspan is currently the main drug doctors have at their disposal to raise ... Forbes US FDA approves Abbott's coated Niaspan - Apr 6, 2007 NEW YORK, April 6 (Reuters) - Abbott Laboratories Inc. (ABT.N) said on Friday the US Food and Drug Administration has approved a new coated time-released ... Reuters Pfizer's Worst-Case Scenario - Dec 3, 2006 The Niaspan product is already on the market and is in a different ... It does have its own side-effect issues, but the next-generation Niaspan Low Flush ... TheStreet.com - TheStreet.com (subscription) FDA OKs Abbott's Simcor combo cholesterol pill - Feb 15, 2008 Niaspan had 2007 sales of $658 million, so Simcor should significantly boost Abbott's cholesterol franchise. Merck is working on a similar product that ... Reuters UK Experimental Merck Drug Using Niacin May Cut Cholesterol - Sep 5, 2007 In a statement Tuesday, Abbott Labs, maker of Niaspan, countered that facial flushing is generally a temporary side effect, which can be easily managed with ... FOXNews Kos Pharma shares jump on Barr deal - Apr 13, 2005 The two companies had been embroiled in patent litigation over Kos' Niaspan and Advocor cholesterol drugs for women. Kos and Barr now will co-promote the ... MarketWatch … New Drug Application for Combination Niaspan(R)/Simvastatin Tablet. - Apr 20, 2007 ABBOTT PARK, Ill., April 20 /PRNewswire-FirstCall/ -- Abbott submitted its New Drug Application to the Food and Drug Administration for a fixed-dose ... Free with registration - PR Newswire - AccessMyLibrary.com Kos Pharma Gets Handed a Lead - Sep 18, 2006 These delays provide Kos with the opportunity to bring its own low-flush niacin product, Niaspan CF, as well as its combination HDL/LDL product Simcor to ... TheStreet.com - TheStreet.com (subscription) Kos Pharma, Barr in Niaspan patent-settlement talks. - Mar 30, 2005 BOSTON (MarketWatch) -- Kos Pharmaceuticals Inc. and Barr Laboratories said Wednesday that they're holding discussions on a possible patent settlement, ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Merck's Good Cholesterol Battle - Aug 30, 2007 That drug, Niaspan, took over the Niacin market and made Jaharis a ... Now Abbott hopes a new version of Niaspan that is supposed to cause even less ... Forbes Article: Abbott acquires majority of Kos. - Chicago Tribune (Chicago,... - Dec 14, 2006 Article: Kos Announces Introduction of Niaspan In Canada. Business Wire; April 26, ... Niaspan, internally developed by Kos, is indicated in Canada . ... Pay-Per-View - Chicago Tribune - HighBeam Research Kos Announces Introduction of Niaspan In Canada - Apr 26, 2005 Kos Pharmaceuticals, Inc. (Nasdaq:KOSP) announced today that, through its Canadian development and commercialization partner, Oryx Pharmaceuticals, ... RedOrbit … Receives FDA Approval For SIMCOR® (Niaspan® / Simvastatin), A Novel... - Feb 18, 2008 Abbott received US Food and Drug Administration (FDA) approval for SIMCOR®, the first fixed-dose combination of two widely prescribed cholesterol therapies, ... Medical News Today - Medical News Today (press release) KOS Pharma Shares Rise On Merck Delay - Sep 29, 2006 ..."While we had viewed the entry of competition to KOS' Niaspan and ... KOS is developing Simcor, a combo drug consisting of Niaspan and generic Zocor, ... Forbes Abbott says new uses may greatly lift Humira sales - Jul 18, 2007 Abbott acquired Niaspan in December with its $3.7 billion purchase of Kos Pharmaceuticals. (Reporting by Ransdell Pierson) Reuters Biotech, pharma diverge - MarketWatch - Apr 27, 2005 The company said that it had been given final regulatory approval to market a generic version of Kos Pharmaceutical's (NYSE:ABT) drug Niaspan. ... MarketWatch 2008 approval seen for Abbott cholesterol drug - Nov 5, 2007 The drug, Simcor, combines Abbott's long-acting niacin pill, Niaspan, with simvastatin, a generic version of Merck & Co's (MRK.N) popular Zocor cholesterol ... Reuters UK Lower Lp(a) levels are better for heart - Jun 15, 2008 For example, nicotinic acid (niacin or Niaspan) has been shown to have Lp(a)-lowering effects. In women past menopause, the hormone estrogen has been shown ... Pay-Per-View - Chicago Tribune - ProQuest Archiver New heart drug dead, but older choices on hand - Dec 4, 2006 A drug already on the market, Niaspan, raises good cholesterol without serious ... He led the most promising study yet of Niaspan plus a statin drug and has ... msnbc.com Niaspan.(Drug overview) - Jan 22, 2007 Although the niacin in Niaspan is one of the B-complex vitamins, Niaspan isn't taken to prevent deficiencies. In large doses, niacin also lowers cholesterol ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com Parties settle dispute over Niaspan.(BARR Laboratories Inc., Kos … - May 2, 2005 WOODCLIFF LAKE, NJ -- Kos Pharmaceuticals Inc. and Barr Pharmaceuticals Inc. have announced that they have signed copromotion, licensing and manufacturing, ... Free with registration - Chain Drug Review - AccessMyLibrary.com Kos Reports Summary Results of Key Phase IV Research and … - Feb 23, 2006 Niaspan MF is one of the first products to emerge from a dedicated research and ... Niaspan MF showed a significantly improved (p<0.0001) overall flushing ... RedOrbit Euronext - Van genoteerde ondernemingen > Persberichten - Oct 22, 2007 SIMCOR® combines two well-established and leading medications, Niaspan and simvastatin ... Available since 1997, Niaspan is the only available FDA-approved, ... euronext.com Niaspan(R) Approved as a Lipid Metabolism Regulator to Raise the " … - Apr 29, 2005 By Kos Pharmaceuticals, Inc. Kos Pharmaceuticals, Inc. (Nasdaq:KOSP) announced today that, through its Canadian development and commercialization partner, ... RxPG NEWS Can you take Advil (ibuprophen) when taking Niaspan? - Sep 14, 2008 Niaspan is a B Vitamin, nicotinic acid, that is effective in lowering Cholesterol levels (Total and LDL) and increasing the good cholesterol level, HDL. ... HealthCentral.com Niaspan(R) Combined With Low/Moderate Dosed Statin Achieves Better … - Jun 20, 2006 Kos Pharmaceuticals, Inc. (Nasdaq: KOSP) commented today on the results from the COMPELL (COMParative Effects on Lipid Levels of Niaspan and Statins Versus ... RedOrbit … Presented at AHA: Raising HDL-C or ''Good'' Cholesterol With Niaspa... - Nov 15, 2005 The ARBITER 2 study showed that the combination of Niaspan and a statin slowed ... Those who had previously been on placebo were switched to Niaspan.(12) ... RedOrbit What is the difference in taking Niaspan and taking regular Niacin? - Oct 5, 2008 Niaspan, a prescription medication is a long acting form of niacin. This long acting drug can be taken once a day and has less side effects than the shorter ... HealthCentral.com … and Medicaid Services (CMS) Advises Plans Niaspan(R) is Now a Part... - Apr 12, 2006 The new policy allows Plans to cover, or continue coverage of, Niaspan immediately, and enables patients needing Niaspan therapy to contact their healthcare ... Genetic Engineering News - Genetic Engineering News (press release) Abbott Submits New Drug Application For Combination Niaspan®/ … - Apr 23, 2007 Niaspan and simvastatin are two widely prescribed medications for treating ... Niaspan is used to raise HDL "good" cholesterol levels, and simvastatin is ... Medical News Today - Medical News Today (press release) Niacin Extended-Release Tablets Combined With Low/Moderate Dosed … - Jun 22, 2006 Study results showed that patients given Niaspan in combination with a low to moderate ... This research points to combining statin therapy with Niaspan, ... DG News … New Drug Application for Combination Niaspan(R)/Simvastatin... - Apr 20, 2007 First Niaspan and Simvastatin Fixed-Dose Combination Therapy Seeks to Help Patients ... Niaspan and simvastatin are two widely prescribed medications for ... Pay-Per-View - PR Newswire - HighBeam Research Dr. Gott: Husband's night sweats from niacin? - Feb 26, 2008 Niaspan (prescription niacin) is known to cause flushing, sweating, ... While awaiting his appointment, he may wish to discontinue the Niaspan temporarily. ... spokesmanreview.com … Receives Final FDA Approval for Generic Niaspan(R) Extended... - Apr 27, 2005 Barr Receives Final FDA Approval for Generic Niaspan(R) Extended-Release Tablets. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research … FDA Approval of a New Coated Niaspan Tablet. - PR Newswire | … - Apr 6, 2007 Abbott Announces FDA Approval of a New Coated Niaspan Tablet. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Kos opens 2nd Weston office - Sep 20, 2006 Helping the company afford the expansion: its "good cholesterol" producing drugs, Niaspan and Advicor. Profit hit $13.9 million in the second quarter, ... Bizjournals.com … seeks court to block Barr's generic Niaspan.(Kos Pharmaceuticals)(B... - Mar 14, 2005 Kos Pharmaceuticals has filed a motion for a temporary restraining order and a preliminary injunction in the US District Court for the Southern District of ... Free with registration - Pharma Marketletter - AccessMyLibrary.com … Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin), a ... - Feb 15, 2008 Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management. from PR ... Pay-Per-View - PR Newswire - HighBeam Research … Clinical Study on Benefits of Combining Aspirin With Optimized... - Jul 25, 2006 Available since 1997, Niaspan is the only FDA-approved, ... Niaspan is indicated as an adjunct to diet when the response to a diet restricted in saturated ... RedOrbit FDA Approves New Coated Niaspan Tablet for boosting HDL cholesterol - Apr 9, 2007 The US Food and Drug Administration has approved Abbott's new coated Niaspan (niacin extended-release tablets). Niaspan is the leading medication for ... emaxhealth.com Merck KGaA/Kos' Niaspan plus statin reverses AS.(atherosclerosis … - Nov 28, 2005 According to a study presented at the American Heart Association's annual meting in Dallas, Texas, atherosclerosis can be reversed by combining Niaspan ... Free with registration - Pharma Marketletter - AccessMyLibrary.com … Abbott's Simcor, a combination of Niaspan and simvastatin.(Update)... - Mar 1, 2008 The FDA approved Abbott's Simcor, a combination of Niaspan and simvastatin.(Update) ... find Medical Marketing & Media articles. The FDA approved Abbott's ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Niaspan and statin reverses atherosclerosis.(Brief Article) - Nov 26, 2005 Adding prolonged-release nicotinic acid to statin therapy can reverse atherosclerosis and raise HDL cholesterol levels, claimed researchers at the Amercian ... Free with registration - Chemist & Druggist - AccessMyLibrary.com Kos' Niaspan shows good efficacy and AE profile.(Brief Article) - Mar 6, 2006 USA-based speciality drugmaker Kos Pharmaceuticals says that its optimized Niaspan (extended-release niacin) modified formulation shows an improved overall ... Free with registration - Pharma Marketletter - AccessMyLibrary.com SIMCOR Significantly Raises HDL, Lowers Triglycerides In Phase III … - Nov 6, 2007 SIMCOR combines two well-established and leading medications, Niaspan and ... Patients in the low-dose group were randomized to receive Niaspan 2000 ... emaxhealth.com Kos reports benefits of combining aspirin with Niaspan. - Jul 31, 2006 Kos reports benefits of combining aspirin with Niaspan. Kos Pharmaceuticals of the USA has announced results from a study that demonstrates the benefits of ... $9.94 - Pharma Marketletter - Alacra Store Q1 2005 Kos Pharmaceuticals Earnings Conference Call - Final. - May 3, 2005 As noted, we also reached new heights in our market share of the cholesterol market with Niaspan and Advicor, which I will cover in a moment. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Abbott Laboratories at Merrill Lynch Global Pharmaceutical, … - Feb 7, 2007 Through the Kos acquisition, we added NIASPAN to our portfolio, ... NIASPAN fits well into our product mix given the current market trend towards HDL ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Euronext - Van genoteerde ondernemingen > Persberichten - Dec 3, 2008 SIMCOR® combines two well-established and leading medications, Niaspan and simvastatin ... Available since 1997, Niaspan is the only available FDA-approved, ... euronext.com First-Time Generic Approvals: Niaspan, Allegra-D 12 Hour, Monistat 3 - May 3, 2005 May 3, 2005 — The US Food and Drug Administration has approved first-time generic formulations of niacin extended-release 500-, 750-, and 1000-mg tablets ... Medscape … Pharma (KOSP) Submits sNDA To FDA For New Niaspan CF Range of … - Jul 12, 2006 Kos Pharmaceuticals, Inc. (Nasdaq: KOSP) submitted a supplemental New Drug Application for a complete dosage range of Niaspan Caplet Formulation products ... StreetInsider.com - StreetInsider.com (subscription) Niaspan approval.(Branded Drugs)(Abbott Laboratories (Abbott Park, … - Apr 23, 2007 Abbott Laboratories has received FDA approval for Niaspan, a medication for ... Niaspan is the only once-daily extended-release niacin for the treatment of ... Free with registration - Chain Drug Review - AccessMyLibrary.com Kos Reports 63% Increase in Revenue to $153 Million and Net Income … - May 3, 2005 Niaspan(R) revenue grew 34% to $94.3 million in the first quarter of 2005 ... Niaspan continues to benefit from the increased detailing efforts from Kos' ... $4.95 - Business Wire - ECNext A new study raises fresh concerns about Zetia and its cousin,... - May 22, 2008 One they are trying is Niaspan, a slow-release version of niacin, ... Both are sold by Merck & Co. of Whitehouse Station, NJ Niaspan is made by North ... Gainesville Sun Event Brief of Q4 2005 Kos Pharmaceuticals Earnings Conference Call -... - Feb 23, 2006 Niaspan MF. 2. KOSP completed and has now reported on the topline results of the ... s key Phase III programs involving Niaspan/simvastatin dyslipidemia and ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com COMPELL: Comparative Effects on Lipid Levels of Niaspan and Statins - Jul 28, 2006 The results of the COMParative Effects on Lipid Levels of Niaspan and statins versus other lipid therapies (COMPELL) trial showed that in patients at high ... Medscape Q4 2006 Abbott Laboratories Earnings Conference Call - Part 2. - Jan 2, 2007 With our acquisition of Kos, we've added Niaspan to our on-market portfolio, ... Niaspan fits very well into our product mix given the current market trends ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Kos Reports Continued Double Digit Increase in Revenue, Financial … - Sep 5, 2006 Specifically, thenew optimized Niaspan MF showed a statistically significant (p lessthan .0001) reduction in the severity of flushing (by 42%), ... FINANZEN.NET NEWS - FINANZEN.NET NEWS Kos, Barr Settle Niaspan Patent Dispute | Article from AP Online | … - Apr 13, 2005 Kos, Barr Settle Niaspan Patent Dispute ... find AP Online articles. AP Online 04-13-2005 Dateline: WOODCLIFF, NJ Kos Pharmaceuticals Inc. said Wednesday t. Pay-Per-View - AP Online - HighBeam Research Kos, Barr settle Niaspan patent dispute over cholesterol reducers |... - Apr 13, 2005 Kos, Barr settle Niaspan patent dispute over cholesterol reducers ... find AP Worldstream articles. AP Worldstream 04-13-2005 Dateline: WOODCLIFF, ... Pay-Per-View - AP Worldstream - HighBeam Research International Approvals: Multiferon, Niaspan, Viread - May 2, 2005 May 2, 2005 — The Republic of the Philippines Department of Health has approved a natural human alpha-interferon injection for the second-line treatment of ... Medscape FDA Approves Coated Niaspan Extended-Release Tablets - Apr 10, 2007 The FDA has approved Abbott Laboratories' new coated Niaspan (niacin) extended-release tablets, indicated for the treatment of lipid disorders with an ... Facts and Comparisons Generic Niaspan approved.(PRODUCTS)(Brief Article) - Jul 1, 2005 A generic version of Niaspan (niacin extended-release tablets, Kos Pharmaceuticals Inc.) is approved. The 500-mg, 750-mg, and 1000-mg extended-release ... Free with registration - Internal Medicine News - AccessMyLibrary.com Article: Niaspan plus statin therapy reduces athersclerotic progressio... - Mar 22, 2005 Niaspan plus statin therapy reduces athersclerotic progression.(Meetings Round-Up)(Brief Article) ... find Diabetes and Primary Care articles. Pay-Per-View - Diabetes and Primary Care - HighBeam Research `Good' Cholesterol Pills May Help Drugmakers' Financial Health - Dec 12, 2005 Niaspan is the first of what doctors, drugmakers and investors say may be the ... Sales of Niaspan, approved in 1997, jumped 37 percent in the first nine ... Bloomberg Abbott may gain as rivals feel pain - Apr 3, 2008 Niaspan, which includes niacin, a B vitamin found to raise HDL, had sales of more ... Reddening is a side effect common to niacin-based drugs like Niaspan, ... Pay-Per-View - Chicago Tribune - ProQuest Archiver Abbott buys cholesterol drug specialists Kos - Nov 9, 2006 Kos Pharmaceuticals' two lead products are Niaspan (niacin extended-release tablets), which works by raising levels of HDL or good cholesterol levels; ... Pharmafocus Q2 2006 Kos Pharmaceuticals Earnings Conference Call - Part 2. - Aug 8, 2006 Like obviously with the Takeda co-promotion, they were detailing Niaspan and Advicor in various detailing positions, whether it be position 1, position 2, ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Product news from the 04/24/07 news brief - Apr 24, 2007 Niaspan and simvastatin, are two widely prescribed medications for treating ... Niaspan is used to raise HDL "good" cholesterol levels, and simvastatin is ... Medical Marketing & Media - Medical Marketing and Media Article: Niaspan approval.(Branded Drugs)(Abbott Laboratories (Abbott... - Apr 23, 2007 Niaspan approval.(Branded Drugs)(Abbott Laboratories (Abbott Park, Illinois) approved by Food and Drug administration)(Brief article) ... find Chain Drug ... Pay-Per-View - Chain Drug Review - HighBeam Research Kos files to block Barr generic - Mar 10, 2005 The court order filing seeks to block the potential launch of generic versions of Niaspan 500mg, 750mg and 1000mg extended-release tablets (Niacin ... Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow Jones Generic Niaspan approved.(Products)(Brief Article) | Article from... - Oct 1, 2005 Generic Niaspan approved.(Products)(Brief Article) ... find Family Practice News articles. A generic version of Niaspan (niacin extended-release tablets, ... Pay-Per-View - Family Practice News - HighBeam Research Article: Parties settle dispute over Niaspan.(BARR Laboratories Inc.,... - May 2, 2005 Parties settle dispute over Niaspan.(BARR Laboratories Inc., Kos Pharmaceuticals Inc. to copromote) ... find Chain Drug Review articles. Pay-Per-View - Chain Drug Review - HighBeam Research … Kos in Settlement Discussions Regarding Niaspan(R) Patent Litigatio... - Mar 30, 2005 Barr and Kos in Settlement Discussions Regarding Niaspan(R) Patent Litigation; Court Agrees to Discontinue Further Proceedings to Allow Parties to Negotiate ... Pay-Per-View - PR Newswire - HighBeam Research Solvay Pharmaceuticals to Co-Promote Abbott's SIMCOR in the United … - Oct 28, 2007 SIMCOR combines two well-established and leading medications, Niaspan and simvastatin, to target multiple lipid parameters - LDL "bad" cholesterol, HDL, ... webwire.com Torcetrapib's failure raises new questions - Jan 1, 2007 Niaspan, marketed by Kos Pharmaceuticals, can do what torcetrapib aimed to. ... Dr. Greg Brown, who is leading the federal study of Niaspan plus Zocor, ... Medical Marketing & Media - Medical Marketing and Media Niacin: Myths and Facts - Dec 17, 2007 Besides prescription Niaspan®, I've used the slow-release preparation ... Slow-release niacin preparations like Niaspan® and SloNiacin® should only be taken ... HealthCentral.com Niaspan + statin = lower CV risk? - Sep 7, 2005 Combining nicotinic acid prolonged-release tablets with simvastatin may be more effective at preventing cardiovascular events than simvastatin alone, ... $4.95 - Community Pharmacy - ECNext Barr and Kos in settlement talks over Niaspan.(BARR Laboratories... - Apr 4, 2005 US firms Barr Pharmaceutical and Kos Pharmaceuticals have said they are engaged in discussions to settle the outstanding patent litigation regarding the ... $4.95 - Pharma Marketletter - ECNext Kos to Report Third Quarter Results on November 9, 2006 Conference … - Nov 9, 2006 ...and general corporate development activities. The Company currently markets Niaspan ® , Advicor ® , Azmacort ® , Cardizem ® LA, Teveten ® and Teveten ® HCT. businesswire.com Event Brief of Q1 2006 Kos Pharmaceuticals Earnings Conference Call -... - May 9, 2006 The Phase III studies for Simcor (Niaspan/simvastatin) combination products ... Niaspan/lovastatin ICPOP study, the first of two Phase III studies designed ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Kos Pharmaceuticals To Report Fourth Quarter And Year End Results On ... - Mar 3, 2005 The Company currently markets Niaspan(R) and Advicor(R) for the treatment of cholesterol disorders, and Azmacort(R) for the treatment of asthma. ... businesswire.com First Horizon Evaluates Triglide Drug Combo - Jan 23, 2006 ...(atorvastatin calcium), and Kos Pharmaceuticals' Niaspan (niacin) on the pharmacokinetics and safety of a single dose of Triglide (fenofibrate) tablets. ... RedOrbit Niacin (Nicotinic Acid) -- The Old Drug Is Making a Comeback With A... - May 31, 2007 Atherosclerosis. 2007 Jan 18; [Epub ahead of print]. Abbott submits New Drug Application for combination Niaspan[R]/simvastatin tablet. April, 23, 2007. ... Medscape Niaspan + statin = lower CV risk? - Sep 7, 2005 Combining nicotinic acid prolonged-release tablets with simvastatin may be more effective at preventing cardiovascular events than simvastatin alone, ... Pay-Per-View - Community Pharmacy - Factiva, from Dow Jones New drug may ease 'flushing' linked to cholesterol treatment - Apr 2, 2008 The other half received Niaspan, an extended-release form of niacin sold by ... Twice as many patients in the Niaspan group reported using aspirin in an ... Los Angeles Times Kos Pharmaceuticals at Bear Stearns 19th Annual Healthcare … - Sep 12, 2006 Our core products are Niaspan, a combination Niaspan with lovastatin called ... When you add Niaspan to a statin like Lipitor or Zocor, you can reduce ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Q4 2005 Kos Pharmaceuticals Earnings Conference Call - Part 2. - Feb 23, 2006 First on the flushing data from Niaspan MF, is there a standard scale for measurement of ... So in the assessments of our optimized formulation of Niaspan, ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Article: Other Drugs Do What Pfizer's Aimed to Do - AP Online |... - Dec 5, 2006 A drug already on the market, Niaspan, raises good cholesterol without serious ... He led the most promising study yet of Niaspan plus a statin drug and has ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Q3 2005 Kos Pharmaceuticals Earnings Conference Call - Part 1. - Nov 3, 2005 A continued focus on quality medical education and with Niaspan and Advicor ... Finally, the Barr co-promotion of Niaspan and Advicor through the Duramed ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com MK 0524A Merck & Co clinical data (phase II) (hyperlipidemia).(Clinica... - Nov 27, 2006 ...with dyslipidemia showed that treatment with MK 0524 plus extended-release nicotinic acid (NIASPAN) significantly reduced flushing intensity during the ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones A Second Bullet For Cholesterol - Dec 5, 2005 But Niaspan is far from the blockbuster the drug industry is seeking. ... Niaspan, at a fraction of the price, brought in about $400 million. ... BusinessWeek Event Brief of Barr Pharmaceuticals, Inc. to Discuss Agreements... - Apr 13, 2005 This sales force will be available to co-promote Niaspan and Advicor to OB-GYN. 2. ... The Co. expects final approval on the Niaspan products shortly. 2. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com FINAL TRANSCRIPT - May 22, 2008 Japan; Simcor, our fixed dose combination therapy of Niaspan and Simvastatin ... In the current Abbott portfolio we have Niaspan, our HDL raising therapy. ... $54.00 - Thomson StreetEvents - Alacra Store It's enough to make them sick - Mar 26, 2006 One of my medications is Niaspan. It's an extended-release form of niacin, ... 6, Niaspan was on the formulary. We even called up and confirmed with an ... Boston Globe Amid worry over Pfizer cholesterol drug setback, effective older drug... - Dec 19, 2006 A drug already on the market, Niaspan, raises good cholesterol without serious ... He led the most promising study yet of Niaspan plus a statin drug and has ... Sauk Valley Newspapers Raising 'Good' Cholesterol Levels Still a Worthy Goal - Dec 11, 2006 In the meantime, doctors and patients already have Niaspan, ... Niaspan is less potent than torcetrapib. "Niaspan also raises HDL but to a lesser extent," ... Washington Post Bourse, cours des actions, CAC 40 - La bourse en ligne - LCI -... - Mar 12, 2008 Le SIMCOR® combine en une seule pilule deux médicaments de pointe bien établis, le Niaspan et la simvastatine, qui ciblent plusieurs paramètres lipidiques ... TF1 |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |